CSLLY News and Press, CSL Ltd ADR From 08/22/22

A review decision by the European Medicines Agency (EMA) is expected in the second half of 2023 If approved, sparsentan will be a first-in-class treatment to address the significant unmet medical need in IgA nephropathy (IgAN) in Europe SAN DIEGO and ST. GALLEN, Switzerlan...

The Swiss Agency for Therapeutic Products (Swissmedic) approved Cara Therapeutics ( NASDAQ: CARA ) and Vifor Fresenius Medical Care Renal Pharma's Kapruvia (difelikefalin) to treat moderate-to-severe pruritus (itching) associated with chronic kidney disease ...

CSL Announces Positive Top-Line Phase 3 Results for Garadacimab as Preventive Treatment in Patients with Hereditary Angioedema (HAE) PR Newswire CSL is on track to file for regulatory approvals at the end of the current fiscal year and will present full data set at an ...

CSL Limited (CSLLY) Q4 2022 Earnings Conference Call August 16, 2022 21:00 ET Company Participants Mark Dehring - Head, Investor Relations Paul Perreault - Chief Executive Officer Joy Linton - Chief Financial Officer Paul McKenzie - Chief Operating Officer ...

The following slide deck was published by CSL Limited in conjunction with their 2022 Q4 earnings call. For further details see: CSL Limited 2022 Q4 - Results - Earnings Call Presentation

CSL announces carbon emissions reduction targets PR Newswire MELBOURNE, Australia , Aug. 16, 2022 /PRNewswire/ -- CSL Limited (ASX: CSL) Today, CSL advances its vision for a more sustainable future by setting new, tangible targets for carbon emissions...

CSL LAUNCHES NEW UNIFIED GLOBAL BRAND IDENTITY PR Newswire All business units will incorporate CSL name and branding to signify one company MELBOURNE, Australia , Aug. 10, 2022 /PRNewswire/ -- Global biotech leader CSL today announced that all bus...

The Project $1M portfolio has had a major leg down in the first half of 2022. Relatively good performances from Visa and Mastercard were unable to offset large declines in Sea Ltd and Meta. While share prices are done, core business performance from many companies that have report...

CSL Plasma Reimagines Donor Experience With First Donations Completed on Innovative Plasma Collection Technology PR Newswire New technology is designed to reduce collection time and improve donor experience; Aurora, Colorado , location is first of 300-plus CSL Plas...

All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead the business as General Manager upon settlement of the offer ...